This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fuchs, P. C. Articles by Brown, S. D. Search for Related Content PubMed PubMed Citation Articles by Fuchs, P. C. Articles by Brown, S. D.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Jan 1997, 125-131, Vol 35, No. 1
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group

PC Fuchs, AL Barry and SD Brown
Clinical Microbiology Institute, Tualatin, Oregon 97062, USA.

Two hundred twenty-eight strains of Haemophilus influenzae and 234 strains of Streptococcus pneumoniae were tested by broth microdilution and disk diffusion methods for susceptibility to trimethoprim (TMP) and TMP-sulfamethoxazole (SMX) to evaluate proposed criteria. Data are presented to support the proposed TMP MIC breakpoints of < or = 2.0 micrograms/ml for susceptibility and > or = 4.0 micrograms/ml for resistance for both species and TMP-SMX MIC breakpoints of < or = 2.0- 38 micrograms/ml for susceptibility and > or = 4.0-76 micrograms/ml for resistance. Corresponding zone diameter breakpoints for H. influenzae for both drugs are proposed: < or = 10 mm = resistant; > or = 16 mm = susceptible. A 10-laboratory study documented reproducibility of such tests with standard control strains. The following control limits are proposed for tests of H. influenzae ATCC 49247 against TMP; MIC, 0.12 to 0.5 microgram/ml; zone diameter, 27 to 33 mm. The current limits for TMP-SMX were confirmed. For tests of S. pneumoniae ATCC 49619, MICs of TMP were 1.0 to 4.0 micrograms/ml and the current TMP-SMX MIC range was confirmed. Disk susceptibility tests of either drug against pneumococci were not reproducible, and consequently neither quality control limits nor interpretive criteria could be established. Endpoint interpretation and lot-to-lot variability in Mueller-Hinton agars were significant factors leading to interlaboratory variability.

This article has been cited by other articles:

• Lovgren, M., Dell'Acqua, L., Palacio, R., Echániz-Aviles, G., Soto-Noguerón, A., Castañeda, E., Agudelo, C. I., Heitmann, I., Brandileone, M. C., Zanella, R. C., Rossi, A., Pace, J., Talbot, J. A., The Pneumococcal Study Group, (1999). Determination of Trimethoprim-Sulfamethoxazole Resistance in Streptococcus pneumoniae by Using the E Test with Mueller-Hinton Agar Supplemented with Sheep or Horse Blood May Be Unreliable. J. Clin. Microbiol. 37: 215-217 [Abstract] [Full Text]  
• Roberts, M.C. (1998). Antibiotic Resistance in Oral/Respiratory Bacteria. CROBM 9: 522-540 [Abstract] [Full Text]